Home > Search: Halotussin AC

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Main Topic Area Halotussin AC All Topic Areas 1 - 10 of 117  more >> Hydrogen cyanide AC Guaifenesin and Codeine Oral Solution or Syrup Brontex Liquid Cheracol Cough Syrup Diabetic Tussin C Gani-Tuss NR Guaituss AC Syrup Halotussin AC Mytussin AC Cough Syrup News 1 - 5 of 13  more >> New Fellowship To Study Multiple Sclerosis, University Of Queensland, Australia MedicalNewsToday - Mon, 26 Feb 2007 08:00 EST Rural, Urban Hospitals Expected To Receive Millions Of Dollars In Additional Funding Under Medicare Prospective Payments System For Inpatient Care, Ac MedicalNewsToday - Fri, 12 Jan 2007 12:00 EST Mucinous Adenocarcinoma Of The Prostate Does Not Confer Poor Prognosis MedicalNewsToday - Tue, 02 Jan 2007 09:00 EST A Great Honor For Professor Metcalf MedicalNewsToday - Thu, 14 Dec 2006 04:00 EST UQ Vice-Chancellor Questions Vaccine Denial In Australia MedicalNewsToday - Tue, 14 Nov 2006 01:00 EST Clinical Trials 1 - 5 of 16  more >> A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer ClinicalTrials.gov Identifier: NCT00190489 - Active, not recruiting Breast Cancer; Neoplasm Metastasis DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension ClinicalTrials.gov Identifier: NCT00389675 - Recruiting Hypertension Biologic Correlative Taxotere/AC ClinicalTrials.gov Identifier: NCT00206466 - Active, not recruiting Breast Cancer Study of Dose-Dense Adriamycin Plus Cytoxan (AC) Followed by Either Abraxane or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer ClinicalTrials.gov Identifier: NCT00394251 - Active, not recruiting Breast Cancer DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension ClinicalTrials.gov Identifier: NCT00389779 - Recruiting Hypertension

GoldBambooTM Your Integrative Health and Wellness Resource November 25, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.